ProCE Banner Activity

HIV and Aging at CROI 2025

Conference Coverage
Clinical Thought

In spite of advances in HIV care, people living with HIV are still at increased risk for age-associated comorbidities, often at a younger age than people without HIV. In this commentary, learn how studies presented at CROI 2025 demonstrate that contemporary treatments for HIV and HIV-associated comorbidities could have positive effects on aging-related outcomes.

Released: April 02, 2025

Expiration: April 01, 2026

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Disclosure

Primary Author

Daniel R. Kuritzkes, MD: consultant/advisor/speaker: AbbVie, Decoy, Gilead, GlaxoSmithKline, Janssen, Merck, Moderna, Pfizer, Shionogi, ViiV.